Snapshot

The Emergency Use Authorization pathway has been developed by the of Indonesia.

This pathway can be used where drugs for use in public health emergency.

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

Based on the recommendation of the National Commission Drug Assessment Team and related experts, the POM Agency will issue an EUA with a special number no later than 20 (twenty) working days from the time the document is submitted to the POM Agency.